These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Early triggering of exclusive IFN-gamma responses of human Vgamma9Vdelta2 T cells by TLR-activated myeloid and plasmacytoid dendritic cells. Devilder MC; Allain S; Dousset C; Bonneville M; Scotet E J Immunol; 2009 Sep; 183(6):3625-33. PubMed ID: 19710464 [TBL] [Abstract][Full Text] [Related]
5. Triggering of specific Toll-like receptors and proinflammatory cytokines breaks allergen-specific T-cell tolerance in human tonsils and peripheral blood. Kücüksezer UC; Palomares O; Rückert B; Jartti T; Puhakka T; Nandy A; Gemicioğlu B; Fahrner HB; Jung A; Deniz G; Akdis CA; Akdis M J Allergy Clin Immunol; 2013 Mar; 131(3):875-85. PubMed ID: 23265862 [TBL] [Abstract][Full Text] [Related]
6. Combined Toll-like receptor agonists synergistically increase production of inflammatory cytokines in human neonatal dendritic cells. Krumbiegel D; Zepp F; Meyer CU Hum Immunol; 2007 Oct; 68(10):813-22. PubMed ID: 17961769 [TBL] [Abstract][Full Text] [Related]
7. Dendritic cells in the circulation of women with preeclampsia demonstrate a pro-inflammatory bias secondary to dysregulation of TLR receptors. Panda B; Panda A; Ueda I; Abrahams VM; Norwitz ER; Stanic AK; Young BC; Ecker JL; Altfeld M; Shaw AC; Rueda BR J Reprod Immunol; 2012 Jun; 94(2):210-5. PubMed ID: 22440523 [TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor (TLR) 2-9 agonists-induced cytokines and chemokines: I. Comparison with T cell receptor-induced responses. Ghosh TK; Mickelson DJ; Fink J; Solberg JC; Inglefield JR; Hook D; Gupta SK; Gibson S; Alkan SS Cell Immunol; 2006 Sep; 243(1):48-57. PubMed ID: 17250816 [TBL] [Abstract][Full Text] [Related]
9. Plasmacytoid dendritic cells from human lung cancer draining lymph nodes induce Tc1 responses. Faith A; Peek E; McDonald J; Urry Z; Richards DF; Tan C; Santis G; Hawrylowicz C Am J Respir Cell Mol Biol; 2007 Mar; 36(3):360-7. PubMed ID: 17023687 [TBL] [Abstract][Full Text] [Related]
10. Toll-like receptors in cellular subsets of human tonsil T cells: altered expression during recurrent tonsillitis. Mansson A; Adner M; Cardell LO Respir Res; 2006 Feb; 7(1):36. PubMed ID: 16504163 [TBL] [Abstract][Full Text] [Related]
11. Differential mediator production by dendritic cells upon toll-like receptor stimulation does not impact T cell cytokine expression. Golden JM; LaCasse CJ; Simova DV; Murphy TR; Kurt RA Immunol Lett; 2008 Jun; 118(1):30-5. PubMed ID: 18403024 [TBL] [Abstract][Full Text] [Related]
12. Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I. Miyazaki M; Kanto T; Inoue M; Itose I; Miyatake H; Sakakibara M; Yakushijin T; Kakita N; Hiramatsu N; Takehara T; Kasahara A; Hayashi N J Med Virol; 2008 Jun; 80(6):980-8. PubMed ID: 18428149 [TBL] [Abstract][Full Text] [Related]
13. Expression and function of Toll-like receptors on dendritic cells and other antigen presenting cells from non-human primates. Ketloy C; Engering A; Srichairatanakul U; Limsalakpetch A; Yongvanitchit K; Pichyangkul S; Ruxrungtham K Vet Immunol Immunopathol; 2008 Sep; 125(1-2):18-30. PubMed ID: 18571243 [TBL] [Abstract][Full Text] [Related]
14. Efficient stimulation of T cell responses by human IFN-alpha-induced dendritic cells does not require Toll-like receptor triggering. Bracci L; Schumacher R; Provenzano M; Adamina M; Rosenthal R; Groeper C; Zajac P; Iezzi G; Proietti E; Belardelli F; Spagnoli GC J Immunother; 2008 Jun; 31(5):466-74. PubMed ID: 18463538 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-148/152 impair innate response and antigen presentation of TLR-triggered dendritic cells by targeting CaMKIIα. Liu X; Zhan Z; Xu L; Ma F; Li D; Guo Z; Li N; Cao X J Immunol; 2010 Dec; 185(12):7244-51. PubMed ID: 21068402 [TBL] [Abstract][Full Text] [Related]
16. Quantitative expression of Toll-like receptor-2, -4, and -9 in dendritic cells generated from blasts of patients with acute myeloid leukemia. Schmitt A; Li L; Giannopoulos K; Greiner J; Reinhardt P; Wiesneth M; Schmitt M Transfusion; 2008 May; 48(5):861-70. PubMed ID: 18208411 [TBL] [Abstract][Full Text] [Related]
17. The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus. Domingues R; de Carvalho GC; da Silva Oliveira LM; Futata Taniguchi E; Zimbres JM; Aoki V; da Silva Duarte AJ; Sato MN Br J Dermatol; 2015 Jan; 172(1):48-55. PubMed ID: 24976336 [TBL] [Abstract][Full Text] [Related]
18. Multiple signaling pathways contribute to synergistic TLR ligand-dependent cytokine gene expression in human monocyte-derived macrophages and dendritic cells. Mäkelä SM; Strengell M; Pietilä TE; Osterlund P; Julkunen I J Leukoc Biol; 2009 Apr; 85(4):664-72. PubMed ID: 19164128 [TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8 alpha+ DC correlates with unresponsiveness to imidazoquinolines. Edwards AD; Diebold SS; Slack EM; Tomizawa H; Hemmi H; Kaisho T; Akira S; Reis e Sousa C Eur J Immunol; 2003 Apr; 33(4):827-33. PubMed ID: 12672047 [TBL] [Abstract][Full Text] [Related]
20. Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses. Nizzoli G; Krietsch J; Weick A; Steinfelder S; Facciotti F; Gruarin P; Bianco A; Steckel B; Moro M; Crosti M; Romagnani C; Stölzel K; Torretta S; Pignataro L; Scheibenbogen C; Neddermann P; De Francesco R; Abrignani S; Geginat J Blood; 2013 Aug; 122(6):932-42. PubMed ID: 23794066 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]